We are live on ! Find out more
PC

Pier Capital Portfolio holdings

AUM $755M
1-Year Est. Return 94.38%
This Fund
S&P 500
This Quarter Est. Return
+13.14%
1 Year Est. Return
+94.38%
3 Year Est. Return
+222.94%
5 Year Est. Return
+261.19%
10 Year Est. Return
+2,769.67%
AUM
$727M
AUM Growth
+$27.6M
Cap. Flow
-$18.9M
Cap. Flow %
-2.6%
Top 10 Hldgs %
17.01%
Holding
132
New
15
Increased
61
Reduced
38
Closed
6

Top Buys

Rank Stock Value
1
CAMT icon
Camtek
CAMT
+$8.89M
2
FORM icon
FormFactor
FORM
+$8.4M
3
VRNS icon
Varonis Systems
VRNS
+$8.17M
4
RPD icon
Rapid7
RPD
+$8M
5
MNDY icon
monday.com
MNDY
+$5.88M

Top Sells

Rank Stock Value
1
RYZB
RayzeBio, Inc. Common Stock
RYZB
+$12.2M
2
GSHD icon
Goosehead Insurance
GSHD
+$9.83M
3
BLD
TopBuild
BLD
+$9.44M
4
FIVE icon
Five Below
FIVE
+$8.57M
5
PLAY icon
Dave & Buster's
PLAY
+$7.99M

Sector Composition

Rank Sector Weight
1 Technology 29.75%
2 Healthcare 21.91%
3 Industrials 17.38%
4 Consumer Discretionary 13.53%
5 Consumer Staples 8.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FIVE icon
126
Five Below
FIVE
$13.2B
$5.99K ﹤0.01%
33
-44,489
-100% -$8.57M
DAWN
127
DELISTED
Day One Biopharmaceuticals
DAWN
– –
-258,685
Closed -$3.78M
IMAX icon
128
IMAX
IMAX
$2.81B
– –
-392,643
Closed -$5.9M
PLAY icon
129
Dave & Buster's
PLAY
$361M
– –
-148,355
Closed -$7.99M
SLAB icon
130
Silicon Laboratories
SLAB
$7.3B
– –
-32,165
Closed -$4.25M
FUSN
131
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
– –
-277,111
Closed -$2.66M
RYZB
132
DELISTED
RayzeBio, Inc. Common Stock
RYZB
– –
-195,653
Closed -$12.2M
2 3 4 5
6

Similar funds

HCM
HMI Capital Management San Francisco, California $754M AUM 23.78% 1-Year Est. Return
FSCM
Front Street Capital Management Missoula, Montana $754M AUM 73.72% 1-Year Est. Return
RMC
Resources Management Corp West Hartford, Connecticut $753M AUM 20.77% 1-Year Est. Return
BEC
Blue Edge Capital Richmond, Virginia $753M AUM 18.89% 1-Year Est. Return
MWA
Meridian Wealth Advisors Austin, Texas $756M AUM 21.36% 1-Year Est. Return
TPW
Talon Private Wealth The Villages, Florida $753M AUM
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
MGM
Manchester Global Management London, United Kingdom $749M AUM 37.16% 1-Year Est. Return

Pier Capital's Q1 2024 Portfolio in Review

As of Q1 2024, Pier Capital held 132 positions worth $727M, up 3.9% from $699M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Pier Capital's Q1 2024 filing shows 15 new, 61 increased, 38 reduced and 6 closed positions. Its largest new stake was Camtek: 113,069 shares worth $9.47M. The largest sale was RayzeBio, Inc. Common Stock, an estimated $12.2M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 27% a quarter earlier, followed by Healthcare and Industrials.

  • Pier Capital's largest Q1 2024 buy was Camtek: 113,069 shares worth $9.47M.
  • Pier Capital added most to Q2 Holdings in Q1 2024, an estimated $4.69M increase.
  • Pier Capital's biggest Q1 2024 reduction was Goosehead Insurance, cutting an estimated $9.83M.
  • Pier Capital fully exited RayzeBio, Inc. Common Stock in Q1 2024, selling an estimated $12.2M.
  • Pier Capital's ten largest holdings make up 17% of its $727M portfolio in Q1 2024.
  • Pier Capital opened 15 new positions and closed 6 in Q1 2024.
  • Pier Capital's portfolio value rose 3.9% quarter-over-quarter to $727M.

Based on Pier Capital's 13F filing for Q1 2024, filed 3 May 2024.